APREA THERAPEUTICS INC APRE

US Healthcare Pharmaceutical Preparations
$0.74
-0.5%
52w: $0.59 – $2.08

Latest 13F among current holders filed 1 month ago (May 15, 2026)

Price — last 12 months

research preview data
0.591.332.08
Jun 20, 2025 Jul 2, 2026
Institutional holders
22
+0 QoQ
13F value
$1.7M
+18.4% QoQ
Smart-money holders
3
signal tier ≥ 2
New smart buyers
1
Q1 2026

Institutional value by quarter

$18.7M
Q1 2024
$567.2M
Q2 2024
$5.9M
Q3 2024
$6.8M
Q4 2024
$3.8M
Q1 2025
$3.1M
Q2 2025
$2.4M
Q3 2025
$1.4M
Q4 2025
$1.7M
Q1 2026

Number of holders

25
Q1 2024
29
Q2 2024
23
Q3 2024
27
Q4 2024
27
Q1 2025
24
Q2 2025
23
Q3 2025
22
Q4 2025
22
Q1 2026

Who owns APRE?

Q1 2026 filings
FundTypeSharesValue% of fundChange
AIGH Capital Management LLC ★2Fundamental concentrated1.0M$775K0.2%+174.1%
Vestal Point Capital, LP ★2Fundamental diversified350.0K$267K0.0%New
SPHERA FUNDS MANAGEMENT LTD. Other270.0K$206K0.0%Held
Nantahala Capital Management, LLC ★2Fundamental diversified205.8K$157K0.0%Held
GEODE CAPITAL MANAGEMENT, LLC Index provider119.1K$91K0.0%+190.9%
Scientech Research LLC Quant stat arb60.3K$46K0.0%New
BNP PARIBAS FINANCIAL MARKETS Bank broker39.8K$30K0.0%+45.7%
VANGUARD FIDUCIARY TRUST CO Diversified mechanical38.5K$29K0.0%
RENAISSANCE TECHNOLOGIES LLC Quant stat arb25.1K$19K0.0%New
MORGAN STANLEY Bank broker22.3K$17K0.0%-71.0%
LPL Financial LLC Bank broker21.1K$16K0.0%-19.2%
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical19.6K$15K0.0%
HighTower Advisors, LLC Diversified mechanical13.9K$11K0.0%Held
TWO SIGMA SECURITIES, LLC Market maker13.5K$10K0.0%New
SUSQUEHANNA INTERNATIONAL GROUP, LLP Market maker13.0K$10K0.0%New
BlackRock, Inc. Index provider8.5K$6K0.0%Held
Tower Research Capital LLC (TRC) Market maker5.1K$4K0.0%-34.5%
UBS Group AG Bank broker2.2K$2K0.0%-12.5%
GROUP ONE TRADING LLC Market maker577$4400.0%Held
OSAIC HOLDINGS, INC. Wealth advisor295$2250.0%-1.7%
WealthCollab, LLC Wealth advisor158$1210.0%Held
SBI Securities Co., Ltd. Diversified mechanical16$120.0%+6.7%

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.